Suppliers / Glaxo Wellcome Manufacturing Pte

Glaxo Wellcome Manufacturing Pte

Singapore 2 duplicate records merged Updated 9 July 2026

Glaxo Wellcome Manufacturing Pte is an API manufacturer based in Singapore. Its GMP standing is certified by HSA (SG).

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Dabrafenib SFDA (Saudi Arabia) 1
Lamivudine SFDA (Saudi Arabia) 1
Salmeterol SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Salmeterol API Lamivudine API

Filings and GMP by regulator

Regulator Filings GMP certificates
HSA (SG) None 1

Questions about Glaxo Wellcome Manufacturing Pte

What does Glaxo Wellcome Manufacturing Pte make?
3 molecules are on record against Glaxo Wellcome Manufacturing Pte, including Dabrafenib, Lamivudine and Salmeterol. Each links through to that molecule's full manufacturer list.
Which regulators recognise Glaxo Wellcome Manufacturing Pte's GMP?
Current GMP certificates are on record from HSA (SG). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Glaxo Wellcome Manufacturing Pte comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule Cipla shares 1 molecule Neuland Laboratories shares 1 molecule Natco Pharma shares 1 molecule Industriale Chimica shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates